鼓室内注射糖皮质激素或高压氧治疗难治性突发性耳聋  

Therapeutic Efficacy of Intratympanic Corticosteroid or Hyperbaric Oxygen for Refractory Sudden Hearing Loss

作　　者：李彩云[1,2] 吴旋[1] 

机构地区：[1]中山大学附属第一医院,广东广州510080 [2]广东省东莞市东莞中医院

出　　处：《中国医学创新》2014年第11期14-16,共3页Medical Innovation of China

摘　　要：目的:分析鼓室内注射糖皮质激素或高压氧治疗难治性突发性耳聋的疗效。方法:选择68例(68耳)临床诊断突发性耳聋、经全身糖皮质激素治疗无效的患者,随机分为三组,分别采用鼓室内注射糖皮质激素治疗组、高压氧治疗组和对照组,观察和比较各组治疗效果。结果:鼓室内注射糖皮质激素治疗组总有效率为50.0%,高压氧治疗组总有效率为44.0%,均比对照组高,差异有统计学意义(P<0.05)。鼓室内注射糖皮质激素治疗组和高压氧治疗组疗效比较差异无统计学意义(P>0.05)。结论:鼓室内注射糖皮质激素或高压氧对难治性突发性聋有效,可提高疗效,改善听力。Objective：To determine the therapeutic efficacy of intratympanic corticosteroid or hyperbaric oxygen for refractory sudden hearing loss. Method：68 cases of refractory sudden deafness were treated respectively by intratympanic corticosteroid or hyperbaric oxygen or control.Result：Total effective rate of intratympanic corticosteroid and hyperbaric oxygen were 50.0% and 44.0%,respectively. Compared with control group,there were significant differences（P〈0.05）. Intratympanic corticosteroid showed no better effect on sudden hearing loss than hyperbaric oxygen alone.Conclusion：Intratympanic corticosteroid or hyperbaric oxygen may be considered as treatment option for refractory sudden hearing loss.

关 键 词：突发性耳聋 糖皮质激素 高压氧 鼓室内注射 

分 类 号：R764[医药卫生—耳鼻咽喉科]